NPHL has moved to an electronic ordering system, NUlirt, and it is now the preferred method to order all tests. Once ordered, print a "batch list" (see
NUlirt Guide).
Forms Required - Nulirt batch list or NPHL Test Request Form (completed in entirety) must accompany the specimen to include the following information: symptoms and date of onset, pregnancy status, travel and vaccine history. Testing
will not be performed without all required information.
Please call NPHL Client Services at (402) 559-2440 or toll free at (800) 334-0459 for further clarification.
BACK | PRINT
| Test: |
Lead, Capillary Whole Blood (LEDCAP)
|
| Synonym: |
|
| Method: |
ICP-MS
|
| Availability: |
Monday, Wednesday, Friday by 09:00 AM
|
| Specimen: |
Whole Venous Blood
http://www.reglab.org/reglab/assets/File/UNMC%20Blood%20Spot%20Lead%20Collection%20ver2015(1).pdf
|
| Collection Device: |
EDTA (Lavendar) tube or EDTA (Lavendar) microtainer
NPHL will only accept microtainer specimens collected in Aperek #1031056 or BD #363706 500 µg/dL K2EDTA tubes.
|
| Volume: |
Minimum Volume: 0.3 mL
|
| Storage/Transport: |
Ambient or 2-8 ºC
|
| Unacceptable: |
Clotted or frozen specimen
|
| Specimen Stability: |
Ambient: 1 week
2-8 ºC: 6 months
|
| Reference Interval: |
| <=3.5 µg/dL for children and adults |
| Notification rage >25.0µg/dL |
|
| Critical range >45.0µg/dL |
|
|
| Reportable Disease: |
All resuts greater than 10 µg/dL from Nebraska are reported to the Nebraska Department of Health through the Douglas County Health Department.
|
| Comments: |
Interpretive Data:
CDC Blood Lead Reference Value: 3.5 µg/dL
-
| CDC classification in children (<=15 years of age):= 10µg/dL or as indicated by local health dept. 20-44µg/dL: Same as above. Complete history and physical exam, assess for signs and symptoms. 45µg/dL or higher: Same as above. Medical intervention including physical and neurological exam. Consider chelation therapy. Contact state or local health dept. |
- CDC Classification in Adults (>=16 years of age):
- <3.5 ug/dL: No action needed. Monitor BLL if ongoing exposure
- 3.5-9 ug/dL: Discuss health risks. Minimize exposure. Reduce lead exposure for women who are or may become pregnant
- 10-19 ug/dL: Decrease exposure. Consider removal from lead exposure for certain medical conditions or BLL >10 for extended period. Increase monitoring and repeat BLL in 3 months.
- 20-29 ug/dL: Remove from Lead exposure. Prompt medical evaluation.
- 50-79 ug/dL: Remove from lead exposure. Prompt medical evaluation. Consider Chelation therapy with significant symptoms or signs of lead toxicity.
- >80 ug/g/dL: remove from lead exposure. Urgent medical evaluation. Probably Chelation therapy.
- Source for children: "Recommended Actions Based on Blood Lead Level, CDC, 2021."
- Source for adults: "Recommendations for Medical Management of Adult Lead Exposure, environmental Health Perspectives, 2007"
|
| Revised: |
5/9/2023 |
If you have questions about proper specimen collection, please call
NPHL Client Services at (402) 559-2440 or toll free at (800) 334-0459.
BACK
